Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cumberland Pharmaceuticals stock

Learn how to easily invest in Cumberland Pharmaceuticals stock.

Cumberland Pharmaceuticals is a drug manufacturers-specialty & generic business based in the US. Cumberland Pharmaceuticals shares (CPIX) are listed on the NASDAQ and all prices are listed in US Dollars. Cumberland Pharmaceuticals employs 83 staff and has a trailing 12-month revenue of around $41.2 million.

How to buy Cumberland Pharmaceuticals stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – CPIX. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Cumberland Pharmaceuticals stock price (NASDAQ: CPIX)

Use our graph to track the performance of CPIX stocks over time.

Cumberland Pharmaceuticals shares at a glance

Information last updated 2023-01-25.
Latest market close$2.73
52-week range$1.89 - $3.81
50-day moving average $2.34
200-day moving average $2.34
Wall St. target price$8.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.34

Buy Cumberland Pharmaceuticals stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Cumberland Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cumberland Pharmaceuticals price performance over time

Historical closes compared with the close of $2.73 from 2023-01-27

1 week (2023-01-23) 4.60%
1 month (2022-12-30) 21.33%
3 months (2022-10-28) 8.33%
6 months (2022-07-29) 20.26%
1 year (2022-01-28) -18.26%
2 years (2021-01-29) -13.88%
3 years (2020-01-30) 4.95
5 years (2018-01-30) 6.935

Cumberland Pharmaceuticals financials

Revenue TTM $41.2 million
Gross profit TTM $27.2 million
Return on assets TTM -5.45%
Return on equity TTM -17.8%
Profit margin -16.93%
Book value $2.69
Market capitalisation $38.3 million

TTM: trailing 12 months

Cumberland Pharmaceuticals share dividends

We're not expecting Cumberland Pharmaceuticals to pay a dividend over the next 12 months.

Have Cumberland Pharmaceuticals's shares ever split?

Cumberland Pharmaceuticals's shares were split on a 2:1 basis on 5 July 2007. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Cumberland Pharmaceuticals shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Cumberland Pharmaceuticals shares which in turn could have impacted Cumberland Pharmaceuticals's share price.

Cumberland Pharmaceuticals share price volatility

Over the last 12 months, Cumberland Pharmaceuticals's shares have ranged in value from as little as $1.89 up to $3.81. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cumberland Pharmaceuticals's is 0.2689. This would suggest that Cumberland Pharmaceuticals's shares are less volatile than average (for this exchange).

Cumberland Pharmaceuticals overview

Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate that is in Phase II clinical trial for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Frequently asked questions

What percentage of Cumberland Pharmaceuticals is owned by insiders or institutions?
Currently 45.281% of Cumberland Pharmaceuticals shares are held by insiders and 17.267% by institutions.
How many people work for Cumberland Pharmaceuticals?
Latest data suggests 83 work at Cumberland Pharmaceuticals.
When does the fiscal year end for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals's fiscal year ends in December.
Where is Cumberland Pharmaceuticals based?
Cumberland Pharmaceuticals's address is: 1600 West End Avenue, Nashville, TN, United States, 37203
What is Cumberland Pharmaceuticals's ISIN number?
Cumberland Pharmaceuticals's international securities identification number is: US2307701092
What is Cumberland Pharmaceuticals's CUSIP number?
Cumberland Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 230770109

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site